PharmTech
CONTINUE TO SITE

OR WAIT null SECS

Pharmaceutical Technology
Spotlight
COVID-19 UpdateAnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems
Topic
View MoreAnalytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain
News
All NewsTop NewsIndustry NewsBio/Pharma NewsSupplier NewsNews from EuropeEvents
Publications
All PublicationsPharmTechPharmTech Europe
Resources
Front & CenterPharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers
WebcastsMarketplace
Multimedia
Drug Digest VideosDrug Solutions Podcast
Subscribe
EnewslettersMagazine North AmericaMagazine Europe

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Contacts
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.

Spotlight
  • COVID-19 Update
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
TopicSee All >
  • Analytical Method Development
  • APIs
  • Aseptic Processing
  • Biologic Drugs
  • Drug Delivery
  • Equipment
  • Excipients
  • Formulation
  • Packaging
  • Process Control/PAT
  • Process Development
  • QA/QC
  • Regulatory Action
  • Supply Chain
  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Contacts
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.

Featured Content

Drug Solutions Podcast

Drug Solutions Podcast

Overcoming Poor Solubility Through Accelerated Dissolution

 What Goes Wrong When API Quality is Compromised?; Image: polesnoy - stock.adobe.com

What Goes Wrong When API Quality is Compromised?

The nitrosamines contamination in “sartan” drugs emphasized the importance of risk assessment in API ingredients manufacturing.

Adapting to Solubility/Bioavailability Challenges; Image: Cagkan - stock.adobe.com

Adapting to Solubility/Bioavailability Challenges

Adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline.

Engineering Challenges in Commercial mRNA Vaccine Manufacturing; Image: sopone - stock.adobe.com

Engineering Challenges in Commercial mRNA Vaccine Manufacturing

Addressing key challenges in building commercial-scale mRNA production facilities.

An Integrated Approach to the Data Lifecycle; Image: Maksim Kabakou - stock.adobe.com

An Integrated Approach to the Data Lifecycle

Successful digital transformation in biopharma requires an integrated approach to the data lifecycle.

Automating Packaging of Bio/Pharmaceuticals; Image: Kadmy - stock.adobe.com

Automating Packaging of Bio/Pharmaceuticals

Automation of pharmaceutical packaging saves costs and time, say contract packagers.

Drug Digest; Development and Scalability of ADCs and CGTs

Drug Digest

Development and Scalability of ADCs and CGTs